Cargando…
A liquid biopsy for bronchopulmonary/lung carcinoid diagnosis
No effective blood biomarker exists to detect and clinically manage bronchopulmonary (BP) neuroendocrine tumors (NET). We developed a blood-based 51 NET-specific transcript set for diagnosis and monitoring and evaluated clinical performance metrics. It accurately diagnosed the tumor and differentiat...
Autores principales: | Kidd, Mark, Modlin, Irvin M., Drozdov, Ignat, Aslanian, Harry, Bodei, Lisa, Matar, Somer, Chung, Kyung-Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5805546/ https://www.ncbi.nlm.nih.gov/pubmed/29467960 http://dx.doi.org/10.18632/oncotarget.23820 |
Ejemplares similares
-
A PCR blood test outperforms chromogranin A in carcinoid detection and is unaffected by proton pump inhibitors
por: Modlin, Irvin M, et al.
Publicado: (2014) -
The clinical applications of a multigene liquid biopsy (NETest) in neuroendocrine tumors
por: Malczewska, Anna, et al.
Publicado: (2019) -
Blood transcript analysis and metastatic recurrent small bowel carcinoid management
por: Modlin, Irvin M, et al.
Publicado: (2014) -
Utility of a ready-to-use PCR system for neuroendocrine tumor diagnosis
por: Kidd, Mark, et al.
Publicado: (2019) -
Decoding the Molecular and Mutational Ambiguities of Gastroenteropancreatic Neuroendocrine Neoplasm Pathobiology
por: Kidd, Mark, et al.
Publicado: (2015)